Calidi Biotherapeutics Inc. (NYSE: CLDI) — Healthcare · Share Price, Chart & Market Data
About: Calidi Biotherapeutics, Inc., a biotechnology company, develops targeted therapies to deliver genetic medicines to distal sites of disease. The company offers CLD-101, which is in Phase 1b/2 clinical trial for the treatment of newly diagnosed high grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck cancer, and sarcoma; and CLD-401 for the treatment of metastatic solid tumors. It also offers oncolytic virus platforms, such as NeuroNova and SuperNova. Calidi Biotherapeutics, Inc. was founded in 2014 and is headquartered in San Diego, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.21 (-6.88%)
CLDICalidi Biotherapeutics Inc.
Loading watchlist status…
Trade CLDI now
Calidi Biotherapeutics Inc. share price
CLDI price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
30 Apr, 1:51 am GMT+0
CLDI price performance
-5.182%
5D
-12.756%
1M
-82.322%
YTD
-96.481%
1Y
CLDI price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NYSE rank
N/A
Sector Rank
N/A
Delayed
30 Apr, 1:51 am GMT+0
CLDI details
CLDI Market Signals